Prevalence and clinical significance in our setting of incidental uptake in the thyroid gland found on 18F-fluordeoxyglucose positron emission tomography-computed tomography (PET-CT)

Fletcher, 2008, Recommendations on the use of 18F-FDG PET in oncology, J Nucl Med, 49, 480, 10.2967/jnumed.107.047787 Zhuang, 2015, Growing applications of FDG PET-CT imaging in non-oncologic conditions, J Biomed Res, 29, 189, 10.7555/JBR.29.20140081 McDougall, 2001, Positron emission tomography of the thyroid, with an emphasis on thyroid cancer, Nucl Med Commun, 22, 485, 10.1097/00006231-200105000-00004 Soelberg, 2012, Risk of malignancy in thyroid incidentalomas detected by 18F-fluorodeoxyglucose positron emission tomography: a systematic review, Thyroid, 22, 918, 10.1089/thy.2012.0005 Salvatori, 2007, Clinical significance of focal and diffuse thyroid diseases identified by (18)F-fluorodeoxyglucose positron emission tomography, Biomed Pharmacother, 61, 488, 10.1016/j.biopha.2007.05.001 Youserm, 1997, Clinical and economic impact of incidental thyroid lesions found with CT and MR, Am J Neuroradiol, 18, 1423 Burguera, 2000, Thyroid incidentalomas. Prevalence, diagnosis, significance, and management, Endocrinol Metab Clin N Am, 29, 187, 10.1016/S0889-8529(05)70123-7 Bertagna, 2012, Diagnostic and clinical significance of F-18-FDG-PET/CT thyroid incidentalomas, J Clin Endocrinol Metab, 97, 3866, 10.1210/jc.2012-2390 Leenhardt, 1999, Indications and limits of ultrasound-guided cytology in the management of nonpalpable thyroid nodules, J Clin Endocrinol Metab, 84, 24, 10.1210/jcem.84.1.5418 Nam-Goong, 2004, Ultrasonography-guided fine-needle aspiration of thyroid incidentaloma: correlation with pathological findings, Clin Endocrinol (Oxford), 60, 21, 10.1046/j.1365-2265.2003.01912.x Haugen, 2016, 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer, Thyroid, 26, 1, 10.1089/thy.2015.0020 Cibas, 2009, The Bethesda system for reporting thyroid cytopathology, Thyroid, 19, 1159, 10.1089/thy.2009.0274 Pagano, 2011, Thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography with CT (FDG-PET/CT): clinical and pathological relevance, Clin Endocrinol (Oxford), 75, 528, 10.1111/j.1365-2265.2011.04107.x Boerner, 2000, Glucose metabolism of the thyroid in autonomous goiter measured by F-18-FDG-PET, Exp Clin Endocrinol Diab, 108, 191, 10.1055/s-2000-7743 Kim, 2010, Risk stratification and prediction of cancer of focal thyroid fluorodeoxyglucose uptake during cancer evaluation, Ann Nucl Med, 24, 721, 10.1007/s12149-010-0414-6 Bae, 2009, Incidental thyroid lesions detected by FDG-PET/CT: prevalence and risk of thyroid cancer, World J Surg Oncol, 7, 63, 10.1186/1477-7819-7-63 Van den Bruel, 2002, Clinical relevance of thyroid fluorodeoxyglucose-whole body positron emission tomography incidentaloma, J Clin Endocrinol Metab, 87, 1517, 10.1210/jcem.87.4.8371 Kang, 2003, Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjects, J Clin Endocrinol Metab, 88, 4100, 10.1210/jc.2003-030465 Piwnica-Worms, 2003, Molecular imaging in oncology, 633 Haber, 1997, GLUT1 glucose transporter expression in benign and malignant thyroid nodules, Thyroid, 7, 363, 10.1089/thy.1997.7.363 Schonberger, 2002, Glucose transporter 1 gene expression is related to thyroid neoplasms with an unfavorable prognosis: an immunohistochemical study, Thyroid, 12, 747, 10.1089/105072502760339307 Lin, 2005, Thyroid cancer in the thyroid nodules evaluated by ultrasonography and fine-needle aspiration cytology, Thyroid, 15, 708, 10.1089/thy.2005.15.708 Bogsrud, 2007, The value of quantifying 18F-FDG uptake in thyroid nodules found incidentally on whole-body PET-CT, Nucl Med Commun, 28, 373, 10.1097/MNM.0b013e3280964eae Are, 2007, Histological aggressiveness of fluorodeoxyglucose positron-emission tomogram (FDG-PET)-detected incidental thyroid carcinomas, Ann Surg Oncol, 14, 3210, 10.1245/s10434-007-9531-4 Choi, 2011, Characteristics of primary papillary thyroid carcinoma with false-negative findings on initial (18)F-FDG PET/C, Ann Surg Oncol, 18, 1306, 10.1245/s10434-010-1469-2 Traugott, 2010, Exclusion of malignancy in thyroid nodules with indeterminate fine-needle aspiration cytology after negative 18F-fluorodeoxyglucose positron emission tomography: interim analysis, World J Surg, 34, 1247, 10.1007/s00268-010-0398-3 Kresnik, 2003, Fluorine-18-fluorodeoxyglucose positron emission tomography in the preoperative assessment of thyroid nodules in an endemic goiter area, Surgery, 133, 294, 10.1067/msy.2003.71 Sebastianes, 2007, Role of 18F-fluorodeoxyglucose positron emission tomography in preoperative assessment of cytologically indeterminate thyroid nodules, J Clin Endocrinol Metab, 92, 4485, 10.1210/jc.2007-1043 Barrio, 2016, The incidence of thyroid cancer in focal hypermetabolic thyroid lesions: an 18F-FDG PET/CT study in more than 6000 patients, Nucl Med Commun, 3, 1290, 10.1097/MNM.0000000000000592 Thuillier, 2019, Diagnostic value of FDG PET-CT quantitative parameters and Deauville-like 5 point-scale in predicting malignancy of focal thyroid incidentaloma, Front Med, 12, 24, 10.3389/fmed.2019.00024